CD274 and breast carcinoma: We analyzed the expression of PD-L1 in 149 breast cancer patients and found PD-L1 positive rate was dramatically higher in TNBC patients and associated with poor prognosis (Fig. 1a–c), which was consistent with other studies5,9.